Orca Investment Management LLC Purchases 248 Shares of Cardinal Health, Inc. $CAH

Orca Investment Management LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 0.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,749 shares of the company’s stock after buying an additional 248 shares during the period. Cardinal Health makes up approximately 4.4% of Orca Investment Management LLC’s investment portfolio, making the stock its 6th largest position. Orca Investment Management LLC’s holdings in Cardinal Health were worth $4,830,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CAH. Wellington Management Group LLP grew its stake in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after buying an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI grew its stake in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after buying an additional 927,950 shares in the last quarter. Nuveen LLC acquired a new stake in Cardinal Health during the first quarter worth about $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new stake in Cardinal Health during the first quarter worth about $104,951,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE:CAH opened at $156.86 on Friday. The firm’s 50 day simple moving average is $152.09 and its 200 day simple moving average is $151.21. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The company has a market cap of $37.27 billion, a PE ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the company earned $1.84 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Insider Activity

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at approximately $35,125,658.90. This trade represents a 31.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CAH shares. Argus set a $189.00 price target on shares of Cardinal Health in a research note on Friday, August 22nd. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird raised their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday. Finally, Leerink Partners raised their price target on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.